Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular Atrophy.
Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging.
Prognostic neuroimaging biomarkers of trauma-related psychopathology: resting-state fMRI shortly after trauma predicts future PTSD and depression symptoms in the AURORA study.
Sample size calculations for detecting disease-modifying osteoarthritis drug effects on the incidence of end-stage knee osteoarthritis in clinical trials: Data from the Osteoarthritis Initiative.
Why are clinical trials of glucosamine no longer uniformly positive?
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Why are clinical trials of glucosamine no longer uniformly positive?
McAlindon T. Why are clinical trials of glucosamine no longer uniformly positive? Rheum Dis Clin North Am. 2003 Nov; 29(4):789-801.
View in:
PubMed
subject areas
Clinical Trials as Topic
Conflict of Interest
Glucosamine
Humans
Knee Joint
Osteoarthritis
Research Design
Sample Size
Treatment Outcome
authors with profiles
Timothy Edward McAlindon MD, MPH, MRCP